Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques P Tremblay

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Journal of Neuropathology and Experimental Neurology|November 28, 2018
Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman PrimatesDaniel Skuk, Jacques P Tremblay
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Generation of lentiviral vectors for use in skeletal muscle researchChristophe Pichavant, Jacques P Tremblay
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2014
Clarifying misconceptions about myoblast transplantation in myologyDaniel Skuk, Jacques P Tremblay
Neuromuscular Disorders : NMD|July 4, 2012
Necrosis, sarcolemmal damage and apoptotic events in myofibers rejected by CD8+ lymphocytes: Observations in nonhuman primatesDaniel Skuk, Jacques P Tremblay
Journal of Clinical Medicine|July 29, 2023
Limb-Girdle Muscular Dystrophies Classification and TherapiesCamille Bouchard, Jacques P Tremblay
Journal of Clinical Medicine|September 28, 2023
Portrait of Dysferlinopathy: Diagnosis and Development of TherapyCamille Bouchard, Jacques P Tremblay
Stem Cells Translational Medicine|December 4, 2018
Myotubes Formed De Novo by Myoblasts Injected into the Scar of Myocardial Infarction Persisted for 16 Years in a Patient: Importance for Regenerative Medicine in Degenerative MyopathiesDaniel Skuk, Jacques P Tremblay
Expert Opinion on Biological Therapy|June 17, 2015
Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patientsDaniel Skuk, Jacques P Tremblay
Journal of Muscle Research and Cell Motility|November 19, 2003
Myoblast transplantation: the current status of a potential therapeutic tool for myopathiesDaniel Skuk, Jacques P Tremblay
Current Opinion in Rheumatology|October 22, 2003
Cell therapies for inherited myopathiesDaniel Skuk, Jacques P Tremblay
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Journal of Neuropathology and Experimental Neurology|November 28, 2018
Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman PrimatesDaniel Skuk, Jacques P Tremblay
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Generation of lentiviral vectors for use in skeletal muscle researchChristophe Pichavant, Jacques P Tremblay
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2014
Clarifying misconceptions about myoblast transplantation in myologyDaniel Skuk, Jacques P Tremblay
Neuromuscular Disorders : NMD|July 4, 2012
Necrosis, sarcolemmal damage and apoptotic events in myofibers rejected by CD8+ lymphocytes: Observations in nonhuman primatesDaniel Skuk, Jacques P Tremblay
Journal of Clinical Medicine|July 29, 2023
Limb-Girdle Muscular Dystrophies Classification and TherapiesCamille Bouchard, Jacques P Tremblay
Journal of Clinical Medicine|September 28, 2023
Portrait of Dysferlinopathy: Diagnosis and Development of TherapyCamille Bouchard, Jacques P Tremblay
Stem Cells Translational Medicine|December 4, 2018
Myotubes Formed De Novo by Myoblasts Injected into the Scar of Myocardial Infarction Persisted for 16 Years in a Patient: Importance for Regenerative Medicine in Degenerative MyopathiesDaniel Skuk, Jacques P Tremblay
Expert Opinion on Biological Therapy|June 17, 2015
Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patientsDaniel Skuk, Jacques P Tremblay
Journal of Muscle Research and Cell Motility|November 19, 2003
Myoblast transplantation: the current status of a potential therapeutic tool for myopathiesDaniel Skuk, Jacques P Tremblay
Current Opinion in Rheumatology|October 22, 2003
Cell therapies for inherited myopathiesDaniel Skuk, Jacques P Tremblay
Pageof 14